Samrat Pharmachem Ltd
Samrat Pharmachem Ltd Live Price Chart
Performance
| Previous Close | ₹ 229.3 |
| High | ₹ 229.2 |
| Volume | 234 |
| 52W Range | ₹ 190 - ₹ 333 |
| Open | ₹ 229.2 |
| Low | ₹ 226 |
| Market Cap | ₹ 70.46 Cr |
Samrat Pharmachem Ltd Technicals
| 20 Day | ₹ 232.519 |
| 50 Day | ₹ 235.239 |
| 100 Day | ₹ 233.618 |
| 200 Day | ₹ 244.121 |
| 20 Day | ₹ 234.303 |
| 50 Day | ₹ 242.347 |
| 100 Day | ₹ 229.719 |
| 200 Day | ₹ 225.382 |
Samrat Pharmachem Ltd Fundamentals
| ROCE | -2.568 |
| P/E Ratio | -32.070 |
| P/B Ratio | 1.040 |
| Industry P/E | 1.040 |
| Debt to Equity | 50.859 |
| ROE | -4.858 |
| EPS | -7.140 |
| Dividend Yield | 0.000 |
| Book Value | 220.666 |
| Face Value | 10.000 |
Samrat Pharmachem Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 290.5549 | 286.8339 | 282.9658 | 311.1236 | 222.3846 |
| Total Expenses | 293.5359 | 276.9478 | 280.4456 | 288.5932 | 198.7837 |
| Profit After Tax | -3.312 | 7.1122 | 2.1626 | 16.6305 | 17.1848 |
Samrat Pharmachem Ltd Shareholding Pattern
| Promoter Holdings | 49.091 % |
| FIIs | 3.237 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 41.512 % |
| Others - | 6.161 % |
About Samrat Pharmachem Ltd
Samrat Pharmachem Limited (SPL) was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta. Since then, it focused on lodine Derivatives as their core products. Company is a producer of pharmaceutical chemicals. The intermediates produced are used in pharmaceutical and chemical industries. The Company is amongst the manufacturers who produce for local and international needs of the pharmaceuticals and chemicals industry. The company has two plants producing varied items. SPL started commercial production of Iodine Derivatives in April, 1993. In October 1996, SPL acquired adjoining land for increasing its production capacity to cater to larger markets. The Company floated a new 100% subsidiary company during the year 2003-04 under the name of 'Samrat Remedies Limited' to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals. SPL constructed new factory building in July, 2006. In August 2015, SPL received GMP Compliance Certificate and was awarded with Export House Certificate by Government of India in October 2015. SPL installed machinery for enhancing its production capacity in April 2019. ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 40.45 +0.58 (+1.45%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 494.65 +4.45 (+0.91%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,734.10 +59.55 (+0.89%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 676.00 -14.1 (-2.04%) |
| Abbott India Ltd Pharmaceuticals | ₹ 27,309.10 +1399 (+5.4%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,371.45 -0.8 (-0.06%) |
FAQs on Samrat Pharmachem Ltd
1. Can I buy Samrat Pharmachem Ltd from PL Capital? ›
2. Does Samrat Pharmachem Ltd pay dividends? ›
3. What is the current share price of Samrat Pharmachem Ltd ? ›
4. What is the 52-week high and low of Samrat Pharmachem Ltd ? ›
5. What is the market capitalisation of Samrat Pharmachem Ltd? ›
6. What is the current P/E ratio of Samrat Pharmachem Ltd? ›
7. What is the current P/B ratio of Samrat Pharmachem Ltd? ›
8. What is the shareholding pattern of Samrat Pharmachem Ltd? ›
9. What is the 1-year return of Samrat Pharmachem Ltd? ›
Start SIP in Samrat Pharmachem Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
